Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II Dose-Finding Trial of Ivermectin for Early Treatment of COVID-19
2020-002283-32Phase 2Terminated
- Sponsor
- IRCCS Ospedale Sacro Cuore Don Calabria
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ivermectin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by IRCCS Ospedale Sacro Cuore Don Calabria. Primary endpoint: Number of serious adverse drug reactions (SADR). Started Aug 2020; status: terminated.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002283-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002283-32.